We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Long-term anti-VEGF treatment raises concern about retinal atrophy.
- Abstract
The article focuses on a statement by specialist Frank Holz that long-term anti-vascular endothelial growth factor (VEGF) treatment in patients with age-related macular degeneration (AMD) might trigger or accelerate retinal atrophy, and mentions the comparison of age-related macular degeneration treatment trials (CATT) and inhibition of VEGF in age-related choroidal neovascularization (IVAN) studies.
- Subjects
EYE anatomy; RETINAL diseases; RETINA physiology; VASCULAR endothelial growth factors; CLINICAL drug trials; RETINAL anatomy; BLINDNESS; HEALTH outcome assessment; PRESS; OPERATIVE surgery; TREATMENT effectiveness; DISEASE risk factors; THERAPEUTICS
- Publication
Ocular Surgery News, 2014, Vol 32, Issue 20, p1
- ISSN
8750-3085
- Publication type
Article